Skip to main content

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Introduction

The seventh transvaginal mesh trial in the Philadelphia Court of Common Pleas concluded with the jury declaring a deadlock in the case involving healthcare giant Johnson & Johnson (Ethicon) following four days of deliberation. The trial which began on August 27 ended with the mistrial announcement by Judge Michael Erdos.

The plaintiff, aged 67, was implanted with a Tension Free Vaginal Tape-Obturator system (TVT-O) on April 3, 2008. In subsequent days she experienced vaginal pain, urinary tract infections, vaginal bleeding, and dyspareunia. She underwent revision surgery on September 29, 2009, when her surgeon removed “very tight adhesions of the tension-free vaginal tape on the right periurethral area” and “trimmed” the TVT-O. However, she continued to experience severe complications due to the mesh implant. This is the first trial linked to TVT-O polypropylene mesh design defects.

Lawsuits filed against Ethicon Pelvic Mesh claiming design defect complications and failure to warn allegations are centralized as a part of a multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) overlooked by U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!